Li Y - Search Results

1

Preparation of a mixed-matrix hydrogel of vorinostat for topical administration on the rats as experimental model.

Dai W, Wang C, Yu C, Yao J, Sun F, Teng L, Li Y. Dai W, et al. Among authors: li y. Eur J Pharm Sci. 2015 Oct 12;78:255-63. doi: 10.1016/j.ejps.2015.07.019. Epub 2015 Aug 4. Eur J Pharm Sci. 2015. PMID: 26248300

2

Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.

Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y. Su Z, et al. Among authors: li y. Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1251-6. doi: 10.1248/cpb.57.1251. Chem Pharm Bull (Tokyo). 2009. PMID: 19881277 Free article.

3

Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.

Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX. Su ZX, et al. Pharm Dev Technol. 2011 Aug;16(4):377-84. doi: 10.3109/10837451003739297. Epub 2010 Apr 7. Pharm Dev Technol. 2011. PMID: 20370594

4

Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.

Sun F, Sui C, Teng L, Liu X, Teng L, Meng Q, Li Y. Sun F, et al. Among authors: li y. Int J Pharm. 2010 Sep 15;397(1-2):44-9. doi: 10.1016/j.ijpharm.2010.06.042. Epub 2010 Jun 30. Int J Pharm. 2010. PMID: 20600717

5

Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats.

Sun F, Su Z, Sui C, Zhang C, Yuan L, Meng Q, Teng L, Li Y. Sun F, et al. Among authors: li y. Basic Clin Pharmacol Toxicol. 2010 Aug;107(2):656-62. doi: 10.1111/j.1742-7843.2010.00552.x. Basic Clin Pharmacol Toxicol. 2010. PMID: 20662826 Free article.

6

Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.

Wang L, Wang A, Zhao X, Liu X, Wang D, Sun F, Li Y. Wang L, et al. Among authors: li y. Int J Pharm. 2012 May 10;427(2):284-92. doi: 10.1016/j.ijpharm.2012.02.015. Epub 2012 Feb 23. Int J Pharm. 2012. PMID: 22387369

7

Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats.

Wang A, Wang L, Sun K, Liu W, Sha C, Li Y. Wang A, et al. Among authors: li y. Pharm Res. 2012 Sep;29(9):2367-76. doi: 10.1007/s11095-012-0762-0. Epub 2012 May 2. Pharm Res. 2012. PMID: 22549738

8

Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder.

Teng L, Jiang C, Sun F, Li C, Teng L, Meng Q, Lee RJ, Li Y. Teng L, et al. Among authors: li c, li y. J Microencapsul. 2013;30(2):116-23. doi: 10.3109/02652048.2012.704950. Epub 2012 Aug 3. J Microencapsul. 2013. PMID: 22861176

9

Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.

Sun F, Sui C, Zhou Y, Liu X, Shi Y, Wu Y, Li Y. Sun F, et al. Among authors: li y. Int J Pharm. 2013 Sep 15;454(1):532-8. doi: 10.1016/j.ijpharm.2013.07.041. Epub 2013 Jul 23. Int J Pharm. 2013. PMID: 23891744

10

Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.

Liang R, Zhang R, Li X, Wang A, Chen D, Sun K, Liu W, Li Y. Liang R, et al. Among authors: li y, li x. Eur J Pharm Sci. 2013 Nov 20;50(3-4):502-10. doi: 10.1016/j.ejps.2013.08.014. Epub 2013 Aug 29. Eur J Pharm Sci. 2013. PMID: 23994054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236,218 results

Search Page

Filters